Skip to Main Content

Paper Details

Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression.
Diabetes Care
7
2023
Author NameAffiliation
Myriam G M Hunink
Myriam G M HuninkCenter for Health Decision Science, Harvard T.H. Chan School of Public Health
Bart S FerketInstitute for Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai
  • 1 - 3

Datasets

PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink